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Products of the major histocompatibility complex (MHC) 1 play a key role in 
the  functional  specificity  of cytolytic  T  lymphocytes  (CTL).  Allogeneically 
stimulated CTL have specificity primarily for products of the H-2K and H-2D 
loci of the mouse histocompatibility 2 (H-2) complex (1). A high proportion of 
CTL precursors appear to be committed to react with these allogeneic MHC 
gene products (2-4). 
The  role  of MHC  products  as  target  specificities  for  CTL  was  further 
elucidated by the experiments of Doherty et al. (5). These investigators showed 
that CTL specific for viral antigens required the presence of the stimulating H- 
2 product on the target cell, as well as the inducing viral determinants, to effect 
cytolysis. This observation also applied to syngeneic systems in which CTL were 
induced to chemically modified syngeneic cells (6), non-H-2-1inked histocompat- 
ibility  determinants (7),  and  tumor-specific transplantation  antigens  (8,  9). 
Shearer  (10) originally demonstrated that CTL could be induced in vitro by 
trinitrophenyl (TNP)-modified syngeneic cells and showed that these CTL only 
lysed TNP-coupled spleen targets sharing H-2K or H-2D gene products with the 
responding and stimulating cell populations (H-2 restricted). Burakoffet al. (11) 
extended  these  findings by  showing that  the  observed  H-2  restriction  was 
actually an H-2 preference, as CTL induced by TNP-coupled syngeneic cells 
could lyse TNP-modified allogeneic spleen targets (cross-reactive lysis) though 
to a lesser extent than the cytolysis of TNP-modified syngeneic spleen targets. 
These cross-reacting CTL also had specificity for MHC products on the TNP- 
modified allogeneic  targets  as  demonstrated by  antiserum  and  cold target 
inhibition experiments (11). 
In this communication, we have further examined the cross-reactive CTL 
induced  by  TNP-coupled  syngeneic cells  in  primary  in  vitro  cultures.  We 
demonstrate that there exists significant interstrain variation among inbred 
mouse  strains  in  their  ability  to  produce  cross-reactive  CTL,  and  that  a 
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dominant H-2-1inked gene(s) controls the ability to produce cross-reactive CTL 
under these experimental conditions. 
Materials  and  Methods 
Mice.  6- to 12-wk-old male and female mice of the following strains were employed for these 
studies:  H-2b: C57BL/6J(B6),  C57BL/10Sn(B10); H-2d: B10.D2n,  BALB/cJ;  H-2f: B10.M; H-2k: 
B10.BR,  C3H/HeJ,  CBA/J,  AKR/J;  H-2q: B10.G; H-2':  B10.RIII;  H-2s: B10.S; H-2  v B10.SM. 
(Additional strains  carrying recombinant H-2  haplotypes  are  listed  in Table  III.)  (B10  × 
B10.BR)F1 and (B6  ×  C3H)F1 mice were bred in our colonies.  The M523 (H-2  ka) strain, which 
carries a mutant H-2  k haplotype, was a gift from Dr. I. K. Egorov, Moscow, USSR. 
Generation of Effector cells.  The method used to generate cytotoxic effector T cells to TNP- 
derivatized stimulator cells has been described  previously (12). Briefly,  7 x  106 normal spleen 
cells were co-cultured at 37°C in 16-mm Linbro tissue culture wells (Linbro Chemical Co., New 
Haven, Conn.) with 6 × l0  s TNP-derivatized irradiated (1,500 R) spleen cells for 5 days and then 
assayed. Stimulator and target cells were TNP derivatized by a 10-min incubation  at 37°C in a 10- 
mM solution of trinitrobenzene  sulfonic acid (pH 7.4). 
51Cr Release Assay.  The 5~Cr release assay has been described in detail elsewhere (12). A 4-h 
incubation time was used. Lipopolysaccharide-induced  blast targets were used in some experi- 
ments. These blasts were produced by 2-day incubation of 4 x  l0  s spleen cells in 2 ml of media 
containing  5/~g/ml lipolysaccharide (Difco Laboratories, Detroit, Mich.). Data from experiments 
with blast targets are quantitatively  but not qualitatively  different from those experiments with 
normal spleen targets. 
Data are expressed  as "percent cross-reactive  lysis." Within each experiment, specific release 
was calculated as described elsewhere (12). The equation E-C/FT-C was used, where E is isotope 
release in tubes containing  immune effectors plus targets, C is isotope release in tubes containing 
normal spleen cells and targets (spontaneous release), and FT is maximum isotope release in 
tubes containing  targets after freeze-thawing three times. A level of specific release (usually 30- 
50% of specific release) observed with syngeneic TNP-modified targets was chosen for normaliza- 
tion. At the effector to target ratio producing this level of lysis, the 5~Cr release on allogeneic 
TNP-coupled  targets was determined. The cross-reactive  lysis is the ratio of the specific lysis of 
allogeneic TNP-medified targets divided by the specific lysis of syngeneic TNP-coupled targets. 
Alloantisera.  Alloantisera were  obtained after  four  to  eight  intraperitoneal injections of 
either tumor or spleen cells.  (The  donor-recipient combination used is listed in the legend to 
Table IV).  The  anti-H-2  k +  Ia  k serum was  a  generous giR of Dr.  Mark  Greene, from this 
department. This serum, a B10.D2 anti-B10.A, has a lytic tiber >  1:640. 
The method of antisera blocking has also been previously reported  (12). Briefly,  50 /~l of a 
suspension of 5~Cr-labeled targets is mixed with 50 ~l diluted antisera in a 10  × 75-ram round- 
bottomed tube for 15 min at 37°C before the introduction of 100 ~1 of a suspension of effectors. 
Regression  Analysis.  Calculation of linear regression analysis of data  and the  Pearson's 
product moment correlation were determined by a Wang 760 computer program (Wang Laborato- 
ries, Inc., Lowell, Mass.). 
Results 
CTL  from  H-2 ~ Mice  Do  Not  Exhibit  Cross-Reactive  Lysis.  B10.BR  CTL 
induced by TNP-modified syngeneic cell in vitro are unable to lyse TNP-coupled 
allogeneic B10  (H-2  b)  spleen targets,  i.e.  these  CTL produce no cross-reactive 
lysis, whereas B10 CTL induced by TNP-modified syngeneic cells demonstrate 
cross-reactive lysis on TNP-modified B10.BR spleen targets (Fig. 1). 
Values  or  cross-reactive  and  syngeneic target  lysis mediated by the  same 
effector cell pool were obtained from nine separate experiments, and a  linear 
regression analysis plotted as  shown in Fig.  2.  When  H-2  b CTL generated to 
TNP-modified syngeneic cells were  assayed on H-2b-TNP spleen or H-2k-TNP 
spleen targets, the data fit a  straight line with a  coefficient of correlation (r)  = 
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FIG.  1.  Cross-reactive lysis by B10 (H-2  b) and B10.BR (H-2  k) CTL. B10 anti-B10 TNP CTL 
(dashed line) and B10.BR anti-B10.BR CTL (solid line) were assayed on B10-TNP spleen 
targets  (circles)  and  B10.BR-TNP  spleen  targets  (squares)  at  several  effector to target 
ratios (E/T). Data is expressed as percent of specific release oP~Cr and spontaneous release 
was <  40%. 
CTL  generated  to TNP-modified  syngeneic targets  demonstrated  little  or no 
lysis of H-2b-TNP spleen targets; even when 60-70% specific lysis of H-2k-TNP 
targets was achieved, <10% lysis of H-2b-TNP targets was observed. 
All  animals  homozygous  for  the  H-2  k haplotype,  including  the  congeneic 
B10.BR mice, produce CTL, afLer TNP-modified syngeneic stimulation,  which 
are restricted,  i.e.  fail to cross-reactively lyse TNP-modified allogeneic spleen 
targets  (Fig.  3,  Experiment  1).  This  indicates  that  the  noncross-reactive 
response produced by H-2  k CTL induced by TNP-modified syngeneic stimulation 
is an H-2-asseciated phenomenon as it does not vary with changes in non-H-2- 
linked background genes. 
Further results in Fig.  3  (experiments 2 and 3) show that  (B6  x  C3H)F1 as 
well as (B10  ×  B10.BR)F1 CTL when stimulated with either H-2  b or H-2  k TNP- 
coupled stimulator cells cross-reactively lyse TNP-coupled allogeneic targets. It 
therefore  appears  that  the  cross-reactive  CTL  phenotype  is  inherited  in  a 
dominant  fashion.  It  is evident  in  Fig.  3 that  H-2  k TNP-modified stimulator 
cells are capable of inducing  CTL that  can cross-reactively lyse TNP-coupled 
allogeneic targets.  However, a  comparison of the extent of cross-reactive lysis 
shown by F1 CTL immunized with TNP spleen cells from each parent revealed 
that the H-2b-TNP stimulator cells elicited more cross-reactive lysis than the H- 
2k-TNP stimulator cells. Thus,  H-2  k TNP-modified stimulator cells bear deter- 
minants  which  can  induce  cross-reactive  CTL,  and  this  suggests  that  the 
noncross-reactive CTL phenotype is a characteristic of the H-2 genotype of the 
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Fro.  2.  Correlation of the extent of cross-reactive lysis by H-2  b and H-2  k CTL. H-2  b anti- 
H-2  b  TNP  (open  circles)  and  H-2  k  anti-H-2 k  TNP  CTL  (filled  circles)  were  assayed 
simultaneously on H-2b-TNP and H-2k-TNP spleen targets.  The data  points  were fitted  to  a 
straight  line  by linear  regression analysis,  and a correlation  coefficient  determined. Each 
point represents a separate experiment, and the assays were performed at an effector  to 
target  ratio  of  40:1.  Spontaneous release  of  targets  ranged from 33-42%. 
Next,  we  asked  whether  H-2k-bearing  mice  were  the  only  animals  that 
produced highly H-2-restricted CTL after TNP-modified syngeneic stimulation. 
Table I shQws three experiments utilizing several strains of C57BL/10 congenic 
mice. It can be seen that H-2 congenic mice bearing the H-2  b, H-2  r, H-2  s, and H- 
2  d  haplotypes  produced  cross-reactive  CTL.  C3H.SW  (H-2b),  DBA/2  (H-2d), 
BALB/c (H-2d),  DBAJ1 (H-2q), and A.SW (H-2  s) mice also produce cross-reactive 
CTL  after  TNP-modified  syngeneic  stimulation  (results  not  shown).  It  thus 
appears  that  the  production  of  noncross-reactive  CTL  after  TNP-modified 
syngeneic primary stimulation  is a  unique trait common only to mice bearing 
the H-2  k haplotype. 
Cross-Reactive Lysis  Is  Independent  of Target-Cell Haplotype.  Results 
shown in Table II indicate B10.BR CTL, stimulated with TNP-modified B10.BR 
spleen cells, produce little or no cross-reactive lysis when tested on TNP-coupled 
H-2  b,  H-2  f,  H-2%  H-2  r,  or  H-2  s  targets  whereas  they  lyse  syngeneic  TNP- 
modified targets well.  In contrast,  CTL from B10 or B10.RIII mice stimulated 
with  TNP-modified  syngeneic  cells  demonstrate  considerable  cross-reactive 
lysis on all the TNP-modified allogeneic targets tested. Thus, the defect in H-2  k P.  BILLINGS,  S.  J.  BURAKOFF,  M.  E.  DORF,  AND  B.  BENACERRAF  345 
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FIG.  3.  Dominant  inheritance  of the  cross-reactive  phenotype.  In  experiment  1  CTL 
induced to  TNP-modified  syngeneic cells from several  strains homozygous for the  H-2 k 
haplotype were assessed for cross-reactive lysis.  In experiments 2 and 3  (H-2  b  ×  H-2k)FI 
CTL were induced by either TNP-modified parental strain and assessed for cross-reactive 
lysis.  Data  are  expressed  as  percent  cross-reactive  lysis  as  defined  in  Materials  and 
Methods. Spontaneous release of the target cells ranged from 35to 40%. 
CTL after TNP-modified syngeneic stimulation is also observed when testing 
other  TNP-coupled  allogeneic  targets.  Furthermore,  with  CTL  from  TNP- 
stimulated B10 and B10.RIII mice, which cross-reactively  lyse all TNP-modified 
allogeneic targets tested, the amount of cross-reactive lysis does not correlate 
with any public serological H-2 specificities on the target cells. 
Localization  of the  Gene(s)  Controlling  Cross-Reactive  Lysis.  We  have 
shown that H-2  k CTL induced by TNP-coupled syngeneic cells show a highly H- 
2-restricted specificity in TNP-coupled target lysis, and that the gene(s) control- 
ling this restriction in the specificity of response to TNP-modified cells is H-2 
linked. We next asked where, within the H-2 complex, does this gene(s) reside? 
Table  III  summarizes  several  experiments  utilizing  mice  bearing  intra-H- 
2-recombinant haplotypes.  To  further analyze the  gene(s) controlling cross- 
reactivity in this system, we tested the ability of CTL from several strains of 
mice carrying portions of the  H-2  k haplotype to  produce cross-reactive CTL 
(Table  III).  B10.A.  and  B10.A(4R)  CTL  were highly H-2  restricted in  their 
response to TNP-modified syngeneic cells, localizing the gene(s) controlling this 
response to the left of the I-B subregion, i.e. K and/or I-A. C3H.0L CTL produce 
cross-reactive lysis, also suggesting K-end localization of the gene influencing 
the cross-reactive response.  Both the  A.TH  and  A.TL combination and the 
B10.T(6R)  and  B10.AQR  recombinant pair  produce cross-reactive CTL  after 
TNP-modified syngeneic stimulation.  This  suggests  that  the  presence of k 
alleles in the I region is not sufficient for the production of the noncross-reactive 
cytolytic response. 
Antisera Inhibition of Cross-Reactive Lysis.  It had been previously reported 
by Schmitt-Verhulst and Shearer (13) that mice bearing the k alleles in the K 
end of the H-2 complex were unable to recognize TNP modifications of their own 
H-2D-coded determinants. This defect was exemplified by the inability of B10.A 
(K  k, D  d) mice, when immunized with syngeneic TNP-modified spleen cells, to 346  Ir  GENE  CONTROL OF  CYTOLYTIC T-LYMPHOCYTE  SPECIFICITY 
TABLE  I 
Cross-Reactive Lysis Produced by CTL from C57BL/lO Congenic Mice 
Percent  TNP-modified 
Experi-  Respender cells*  stimulator  TNP-modified  target  cross-re- 
ment  cells*  cells  active 
lysis§ 
1  B10(h-2  b)  B10  B10.SM(H-2 v)  38 
B10.RIII(H-T)  B10.RIII  B10.SM  55 
B10.BR(H-2 k)  B10.BR  B10.SM  4 
2  B10.S(H-2 B)  B10.S  B10  45 
B10.BR  B10.BR  B10  3 
3  B10  B10  B10.RIII  65 
B10.D2(H-2 d)  B10.D2  B10.RIII  36 
B10.BR  B10.BR  B10.RIII  6 
* H-2 haplotypes of various congenic strains are indicated in parentheses. 
* Spontaneous release of TNP-coupled normal spleen targets was <40%. 
§ Effector to target ratios of 50:1 for B10,  40:1 for B10.RIII, and 38:1 for B10.BR 
produced 40% TNP-modified syngeneic specific release in experiment 1. In experi- 
ment 2, effector to target ratios of 35:1 for B10.S and 25:1 for B10.BR produced 35% 
TNP-modified syngeneic specific release. In experiment 3, effector to target ratios 
of 50:1 for B10,  50:1 for B10.D2,  and 30:1 for B10.BR  yielded 50% TNP-coupled 
syngeneic specific release. 
TABLE  II 
Cross-Reactive Lysis of TNP-Modified Allogeneic Targets* 
Percent cross-reactive lysis of TNP-targets§ 
Respender*  B10.BR  B10.M  B10.G  B10.S  B10  B10.RIII 
(H-T)  (H-~)  (H-2  q)  (H-T)  (H-2  ~)  (H-2 r) 
B10  31  41  53  69  100  35 
(40) 
B10.RIII  50  38  59  NT  35  100 
(40) 
B10.BR  100  12  13  10  10  9 
(40) 
* Summary of three separate experiments. 
* Responder cells were co-cultured with TNP-modified syngeneic cells for 5 days, then 
assayed on the TNP-modified syngeneic and allogeneic targets. 
§ Spontaneous release of TNP-modified normal spleen targets was <40%;  H-2 haplotype 
indicated in parentheses; NT, not tested. 
lyse B10.D2-TNP  (K  d,  D d) targets. It was conceivable that  the inability of mice 
bearing  the k  alleles in the H-2 complex to produce cross-reactive responses in 
our system might be due to the same defect that these authors had described. If 
this  were  the  case,  then  most  cross-reactivity would  be directed at  H-2D-end 
determinants,  and the resulting inability of H-2 k haplotype mice to make  cross- 
reactive responses would thus result from the inability of H-2 k CTL to recognize 
TNP-derivatized  H-2D k  determinants.  We  tested  this  hypothesis  by  asking 
whether  CTL  from  mice  that  made  good  cross-reactive responses  after  TNP- P.  BILLINGS,  S.  J.  BURAKOFF,  M.  E.  DORF,  AND  B.  BENACERRAF 
TABLE  III 
Localization of Gene Controlling Cross-Reactive Lysis 
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Respender  H-2 haplo-  H-2  region  formulas$  Percent  cross- 
cells*  type  K  IA  IB  IJ  IC  S  D  reactive  lysis 
B10  b  b  b  b  b  b  b  b  50 
B10.D2  d  d  d  d  d  d  d  d  34 
B10.BR  k  k  k  k  k  k  k  k  7 
A  a  k  ~  k  "~  d  d  d  6 
B10.A(4R)  h4  k  ~-~  b  b  b  b  b  4 
M523  ka  ka  k  k  k  k  k  k  8 
C3H.OL  01  d  d  d  d  d  k  k  42 
A.TH  t2  s  s  s  s  s  s  d  78 
A.TL  tl  s  k  k  k  k  k  d  77 
B10.T(6R)  y2  q  q  q  q  q  q  d  36 
B10.AQR  yl  q  k  k  k  d  d  d  48 
* Summary of several  experiments.  In  each case,  CTL were  stimulated with TNP-modified 
syngeneic spleen cells and tested on TNP-modified syngeneic and allogeneic spleen cell targets. 
Spontaneous release of targets was <40% in all cases. 
$ Arrows indicate localization of gene(s) controlling cress-reactivity. 
modified syngeneic stimulation  directed these responses at H-2K-coded deter- 
minants,  H-2D determinants,  or beth.  Specific antisera  blocking was  used to 
determine which end of the H-2 complex controlled the target antigens for cross- 
reactive responses. The results are shown in Table IV. B6 CTL that have been 
stimulated by TNP-coupled B6 spleen cells lyse A/J (K  k, Dd), B10.BR (K  k, Dk), 
and B10. D2 (K  d, D d) TNP-modified targets. Anti-H-2D  d antisera partially blocks 
killing  of B10.D2-TNP  and  A-TNP  targets.  Furthermore,  anti-H-2K  k  serum 
partially inhibits lysis of B10.BR-TNP and A-TNP targets.  This indicates that 
a significant proportion of cross-reactive lytic activity is directed at H-2K-coded 
products on the cell membranes modified by TNP. Because a significant amount 
of cross-reactive lytic activity is directed at H-2K-coded products, it is unlikely 
that the inability to recognize H-2D TNP modifications in the H-2  k haplotype 
can fully account for the inability of H-2  k mice to produce cross-reactive CTL. 
Therefore, it appears that the genetic defect described by Schmitt-Verhulst and 
Shearer  (13)  is not responsible for the inability of the  mice bearing the  H-2  k 
haplotype to display cross-reactive lysis on TNP-modified allogeneic cells. 
M523  Mutation  Does  Not  Affect  the  Gene(s)  Controlling  Cross-Reactive 
Lysis.  We studied the M523 strain, whose mutation was initially described by 
Blandova et al. (14). Available data support the assertion that the M523-bearing 
mouse possesses  a  point  mutation  of the  H-2K  k structural  gene.  Zaleski  and 
Klein  (15) have shown that this mutation has also affected the Ir gene which 
controls the  immune  response to the cell surface antigen Thy 1.2.  We tested 
cells from M523 mice for their ability to produce cross-reactive CTL after TNP- 
modified syngeneic stimulation.  The results of these experiments could clarify 
the relationship of the gene controlling cross-reactive lysis to the one described 
by Zaleski and Klein (15) and might elucidate the role of H-2K structural genes 
in the control of CTL specificity. 348  Ir  O~.N]Z CONTROL  OF  CYTOLrrm  T-LYMPHOCYTE  SEzcn~cITY 
TABLet  IV 
Antisera Inhibition of Cross-Reactive Lysis by B6 CTL * 
Experi-  TNP-modified  Percent spe- 
ment  target*  cific release§ 
Percent antiserum inhi- 
bition  u 
Anti-H-2K  k  Anti-H-2D  d 
1  A  39  62  53 
B10.BR  28  100  8 
B10.D2  32  0  71 
B6  60  10  14 
2  B10.BR  15  47  6 
B6  28  0  0 
* In both experiments B6 CTL were stimulated with TNP-coupled B6 
spleen  cells. 
, Spontaneous release of  TNP-modified normal spleen  cells  was <40%. 
§ These values are in  the absence of  antiserum. Effector  to  target ratios 
of  40:1  in  experiment I and 15:1  in  experiment 2 were used. 
II  Anti'H'2Kk serum (B10.D2 anti-B10.A) had a lytic  titer  1/500.  Anti-H- 
2D  d  serum [(B10 × LP.RIII)FI anti-18R] has a lytic  titer  1/1,000.  Sera 
were used at  final  dilution of  1:12. 
Data presented in Table V show that M523 CTL induced by TNP-modified 
syngeneic  cells do not cross-reactively  lyse BALB/c or B10 TNP-modified  targets 
and  demonstrate  very  little  lysis  of TNP-modified C3H.OL  targets  which 
theoretically share  identical  H-2D  end  determinants,  suggesting  that  this 
mutation does not affect the gene(s) described by Schmitt-Verhulst and Shearer 
(13). However, the M523 CTL lyse TNP-modified B10.A(4R) targets that carry 
the H-2K  k determinants. Similarly, CBA (H-T) CTL lyse mutant M523 TNP- 
coupled targets, indicating the H-2  k CTL are capable of lysis when tested on 
targets of the closely related H-2  ka TNP-coupled targets, as previously demon- 
strated by Forman and Klein (16). 
Discussion 
To summarize the findings presented in this paper: (a) The specificity of the 
cytolytic in vitro primary response produced by H-2  k CTL,  induced by TNP- 
modified syngeneic cells,  is  highly  H-2  restricted.  (b)  Mice  that  bear  H-2 
haplotypes other than H-2  k produce a  substantial level of cross-reactive CTL 
after TNP-modified syngeneic primary stimulation. (c) The gene(s) controlling 
the specificity of the CTL primary response to TNP-medified syngeneic cells is 
H-2  linked,  and the cross-reactive CTL phenotype is dominant in  F~  hybrid 
mice. (d) Cross-reactive and noncross-reactive CTL maintain their phenotype 
independent of the H-2 haplotype of the TNP-coupled target.  (e) The gene(s) 
controlling this response maps to the K and]or I-A region of the H-2 complex 
and can be distinguished from two other genes that map to these regions. 
Mice bearing the H-2  k haplotype can be induced to exhibit some cross-reactive 
lysis on TNP-modified allogeneic targets if they are initially primed subcuta- 
neously  in  vivo  and  subsequently challenged  in  vitro  with  TNP-medified P.  BILLINGS,  S.  J.  BURAKOFFp  M.  E.  DORF,  AND  B.  BENACERRAF 
TABLE V 
Cytolytic Activity by the Mutant M523 Strain* 
Percent  cross-reac- 
Responder  cells  Modified  target  cells~  tive  lysis§ 
M523  M523  100(60) 
M523  BALB/c  5 
M523  B10  12 
M523  C3H.OL  20 
M523  B10.A(4R)  79 
M523  CBA  80 
CBA  M523  65 
* M523, a CBA mutant, has an H-2 regions of I~  a, I  k, S  k, and D  k. The 
data represent a summary of two experiments. In each case, M523 or 
CBA CTL were stimulated with TNP-medified  syngeneic  spleen cells. 
$ Spontaneous  release of TNP-modified  normal spleen cells was <40%. 
§ Effector  to target ratios of  40:1 and 80:1 gave 60% specific  release from 
the  TNP-modified syngeneic target  (indicated in  parentheses) by 
M523 and CBA CTL. 
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syngeneic cells  (data  not  shown).  The  defect observed in  the  cross-reactive 
response  of  mice  of  the  H-2  k  haplotype,  although  highly  significant  and 
reproducible, appears to be limited to the primary response. 
We have thus described an H-2-1inked defect in the H-2  k haplotype that limits 
its ability to cross-reactively lyse TNP-modified targets when stimulated with 
TNP-coupled syngeneic cells.  When these data are considered along with the 
dominant inheritance of the cross-reactive response and the genetic mapping 
experiments,  we  can  conclude  that  an  immune  response  (Ix)  gene  may  be 
responsible for controlling the specificity of the cytolytic response in the TNP 
system. We refer to this gene as Ir-X-TNP. This gene(s) regulates the ability to 
generate  cross-reactive  CTL  after  presentation  of TNP-modified  syngeneic 
antigens. 
In this present report, we localize the Ir-X-TNP gene(s) to the K  and/or I-A 
region by using the B10.A (4R) recombinant strain. In addition, we have shown 
that the presence ofk alleles in the I region is not suf~cient for an H-2-restricted 
cytolytic response to TNP-modified H-2 antigens. However, inasmuch as all Ir 
gene systems are highly antigen specific, we must note that the TNP-medified 
stimulating determinants from A.TL and B10.AQR strains do not possess the 
H-2K  k determinants.  Hence, the cross-reactivity observed with these strains 
was generated with a  different stimulating antigen.  Further mapping studies 
will be required to definitively localize the Ir-X-TNP gene. 
Several other IX  genes controlling  immune responses to  cell  surface-associated 
antigens appear to map close to the Ir-X-TNP gene (13,  15).  Whether the IX-X- 
TNP  gene codes for a T-cell  recognition defect  or rather controls CTL responses 
by restricting cell-to-cell  collaboration or by allowing regulatory  cells to be 
produced  is unresolved.  Data  presented  in the following  report  suggest  a 
possible mechanism by which the Ir-X-TNP gene controls the CTL response to 
TNP-modified cells. 350  Ir  GENE  CONTROL  OF  CYTOLYTIC  T-LYIVIPHOCYTE  SPECIFICITY 
Summary 
The ability of  cytotoxic T lymphocytes (CTL) induced in vitro to trinitrophenyl 
(TNP)-modified syngeneic cells to cross-reactively lyse a TNP allogeneic spleen 
target varies among inbred mouse strains. The cross-reactive CTL phenotype 
was found to be  histocompatibility 2  (H-2)  linked and to be  dominant in F1 
hybrid mice. All strains investigated demonstrated cross-reactivity except for 
some strains bearing portions of the H-2 k haplotype. The gene(s) controlling 
this response maps to the K  and/or I-A region of the H-2  complex.  We have 
termed the immune response (Ir) gene responsible for controlling the specificity 
of CTL induced to TNP-modified syngeneic cells Ir-X-TNP. 
We wish to thank Dr.  Ronald Germain for his stimulating discussions, and Ms. Diane Cannata 
for her excellent secretarial assistance. 
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